Genetics

In cancer, an embryonic gene-silencing mechanism gone awry

There are some genes that are only activated in the very first days of an embryo's existence. Once they have accomplished their task, they are shut down forever, unlike most of our genes, which remain active throughout our ...

HIV & AIDS

How immune cells defend themselves against HIV

A team of scientists led by virologists Prof. Oliver T. Fackler and Prof. Oliver T. Keppler from Heidelberg University Hospital have decoded a mechanism used by the human immune system to protect itself from HIV viruses. ...

Oncology & Cancer

A possible target for broad-range HPV therapeutics emerges

(Medical Xpress) -- Among viruses, human papilloma virus (HPV) stands out: with more than 180 distinct isotypes or variations catalogued to date, it presents an extremely difficult target for broad-range treatments. And while ...

Diseases, Conditions, Syndromes

Researchers identify promising new drug target for kidney disease

Researchers from Mount Sinai School of Medicine have identified a regulator protein that plays a crucial role in kidney fibrosis, a condition that leads to kidney failure. Finding this regulator provides a new therapeutic ...

Oncology & Cancer

'Get vaccinated,' says HPV expert at UB Medical School

(Medical Xpress) -- A University at Buffalo microbiologist whose lab has been studying the human papilloma virus for years, says that parents should have their children vaccinated with Gardasil, the HPV vaccine.

HIV & AIDS

Hide-and-seek: Altered HIV can't evade immune system

(Medical Xpress) -- Researchers at Johns Hopkins have modified HIV in a way that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, ...

page 11 from 12